Mpande Mukumbwa-Mwenechanya
Overview
Explore the profile of Mpande Mukumbwa-Mwenechanya including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
88
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Maskew M, Ntjikelane V, Juntunen A, Scott N, Benade M, Sande L, et al.
Gates Open Res
. 2024 Feb;
7:119.
PMID: 38343769
Background: For patients on HIV treatment in sub-Saharan Africa, the highest risk for loss from care remains the first six months after antiretroviral (ART) initiation, when patients are not yet...
2.
Sikombe K, Pry J, Mody A, Rice B, Bukankala C, Eshun-Wilson I, et al.
BMJ Open
. 2023 Jul;
13(7):e069086.
PMID: 37407057
Objectives: To compare unannounced standardised patient approach (eg, mystery clients) with typical exit interviews for assessing patient experiences in HIV care (eg, unfriendly providers, long waiting times). We hypothesise standardised...
3.
Girdwood S, Pandey M, Machila T, Warrier R, Gautam J, Mukumbwa-Mwenechanya M, et al.
PLOS Glob Public Health
. 2023 Mar;
3(1):e0001179.
PMID: 36963019
Diagnostic network optimization (DNO), a geospatial optimization technique, can improve access to diagnostics and reduce costs through informing policy-makers' decisions on diagnostic network changes. In Zambia, viral load (VL) testing...
4.
Mukumbwa-Mwenechanya M, Mubiana M, Somwe P, Zyambo K, Simwenda M, Zongwe N, et al.
PLOS Glob Public Health
. 2023 Mar;
3(3):e0000909.
PMID: 36962979
Most people living with HIV (PLHIV) established on treatment in Zambia receive multi-month prescribing and dispensing (MMSD) antiretroviral therapy (ART) and are enrolled in less-intensive differentiated service delivery (DSD) models...
5.
Moore C, Pry J, Mukumbwa-Mwenechanya M, Eshun-Wilson I, Topp S, Mwamba C, et al.
PLOS Glob Public Health
. 2023 Mar;
2(8):e0000108.
PMID: 36962510
Fast Track models-in which patients coming to facility to pick up medications minimize waiting times through foregoing clinical review and collecting pre-packaged medications-present a potential strategy to reduce the burden...
6.
Jo Y, Jamieson L, Phiri B, Grimsrud A, Mwansa M, Shakwelele H, et al.
PLoS One
. 2023 Mar;
18(3):e0280748.
PMID: 36917568
Background: Many sub-Saharan Africa countries are scaling up differentiated service delivery (DSD) models for HIV treatment to increase access and remove barriers to care. We assessed factors associated with attrition...
7.
Jamieson L, Rosen S, Phiri B, Grimsrud A, Mwansa M, Shakwelele H, et al.
BMJ Open
. 2022 Dec;
12(12):e064070.
PMID: 36549722
Objectives: Patient attrition is high the first 6 months after antiretroviral therapy (ART) initiation. Patients with <6 months of ART are systematically excluded from most differentiated service delivery (DSD) models,...
8.
Pry J, Sikombe K, Mody A, Iyer S, Mutale J, Vlahakis N, et al.
BMJ Glob Health
. 2022 Jan;
7(1).
PMID: 35078810
Introduction: The Zambian Ministry of Health (MoH) issued COVID-19 mitigation guidance for HIV care immediately after the first COVID-19 case was confirmed in Zambia on 18 March 2020. The Centre...
9.
Roy M, Bolton-Moore C, Sikazwe I, Mukumbwa-Mwenechanya M, Efronson E, Mwamba C, et al.
PLoS Med
. 2020 Jul;
17(7):e1003116.
PMID: 32609756
Background: Current models of HIV service delivery, with frequent facility visits, have led to facility congestion, patient and healthcare provider dissatisfaction, and suboptimal quality of services and retention in care....
10.
Eshun-Wilson I, Mukumbwa-Mwenechanya M, Kim H, Zannolini A, Mwamba C, Dowdy D, et al.
J Acquir Immune Defic Syndr
. 2019 Apr;
81(5):540-546.
PMID: 31021988
Background: Although differentiated service delivery (DSD) models for stable patients on antiretroviral therapy (ART) offer a range of health systems innovations, their comparative desirability to patients remains unknown. We conducted...